Latest Fund Management News

VanEck Investments Limited has released a comprehensive Product Disclosure Statement for seven Australian bond ETFs, detailing investment strategies, risks, fees, and operational frameworks under ASX AQUA Rules.

InvestSMART Funds Management has updated the Distribution Reinvestment Plan rules for its Intelligent Investor Active ETFs, making DRP participation automatic for new investors from January 2026 unless they opt out.

InvestSMART Funds Management Limited has updated its Distribution Reinvestment Plan rules, making participation automatic for new investors in its Intelligent Investor Active ETFs from January 2026. Existing investors will see no change, but new entrants will need to opt out if they prefer cash distributions.

BTC Health has broadened its medical product portfolio through strategic acquisitions and organic growth, reporting strong early revenue gains while cautiously navigating the uncertain timing of ECMO system adoption.

Ryzon Materials Ltd has lodged a prospectus to raise up to $10 million through a share placement with free-attaching options, aiming to meet ASX conditions for lifting its securities suspension and advancing its Nachu graphite project.

CD Private Equity Fund I reported a $2.6 million net loss for the half-year ended 30 September 2025, driven by foreign exchange impacts and fair value adjustments, while distributing 8 cents per unit amid ongoing portfolio realisations.

Boab Metals has locked in a A$236 million debt facility to advance its Sorby Hills Silver-Lead Project, marking a pivotal step towards production with a clean financing structure that preserves shareholder value.

Hancock & Gore is rebranding as Schoolblazer Limited following its acquisition of Trutex, consolidating its global school uniform operations and targeting over $200 million in revenue by FY27.

Equity Story Group Ltd has secured $1.2 million through a fully subscribed two-tranche placement to accelerate growth in its fund management business and prepare for entry into the property sector in 2026.

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.

Charter Hall Group reported solid FY25 results with 7.4% growth in operating earnings per security and upgraded its FY26 earnings guidance to 95 cents, reflecting robust equity inflows and tenant demand. The company also highlighted significant sustainability progress and board changes at its 2025 AGM.

Charter Hall Group has raised its FY26 operating earnings per security guidance by 5.5%, reflecting robust momentum in property investments and funds management. The upgrade signals growing investor confidence and increased transaction volumes across its platforms.